Impact of Expression and Genetic Variation of microRNA-34b/c on Cognitive Dysfunction in Patients with Major Depressive Disorder

References

• Smith K, De Torres IBC. Mental health: a world of depression. Nature. 2014;515(7526):180–181. doi:10.1038/515180a
   Google Scholar
• Huang Y, Wang Y, Wang H, et al. Prevalence of mental disorders in China: a cross-sectional epidemiological study. Lancet Psychiatry. 2019;6(3):211–224. doi:10.1016/S2215-0366(18)30511-X30792114
   PubMed Web of Science ®Google Scholar
• Belmaker RH, Agam G. Major depressive disorder. N Engl J Med. 2008;358(17):1869. doi:10.1056/NEJMra073096
   Web of Science ®Google Scholar
• Bromet E, Andrade LH, Hwang I, et al. Cross-national epidemiology of DSM-IV major depressive episode. BMC Med. 2011;9(1):90. doi:10.1186/1741-7015-9-9021791035
   PubMed Web of Science ®Google Scholar
• Hartog HMD, Derix MMA, Bemmel ALV, Kremer B, Jolles J. Cognitive functioning in young and middle-aged unmedicated out-patients with major depression: testing the effort and cognitive speed hypotheses. Psychol Med. 2003;33(8):1443–1451. doi:10.1017/S003329170300833X14672253
   PubMed Web of Science ®Google Scholar
• Porter RJ, Bourke C, Gallagher P. Neuropsychological impairment in major depression: its nature, origin and clinical significance. Aust N Z J Psychiatry. 2007;41(2):115–128. doi:10.1080/0004867060110988117464689
   PubMed Web of Science ®Google Scholar
• Hammar A, Ardal G. Cognitive functioning in major depression–a summary. Front Hum Neurosci. 2009;3:26. doi:10.3389/neuro.09.026.200919826496
   PubMed Web of Science ®Google Scholar
• Harvey PO, Le Bastard G, Pochon JB, et al. Executive functions and updating of the contents of working memory in unipolar depression. J Psychiatr Res. 2004;38(6):567–576. doi:10.1016/j.jpsychires.2004.03.00315458852
   PubMed Web of Science ®Google Scholar
• Rogers MA, Kasai K, Koji M, et al. Executive and prefrontal dysfunction in unipolar depression: a review of neuropsychological and imaging evidence. Neurosci Res (N Y). 2004;50(1):1–11. doi:10.1016/j.neures.2004.05.00315288493
   PubMedGoogle Scholar
• Lee Rico SC, Hermens Daniel F, Porter Melanie A, Redoblado-Hodge MA. A meta-analysis of cognitive deficits in first-episode major depressive disorder. J Affect Disord. 2012;140(2):113–124. doi:10.1016/j.jad.2011.10.02322088608
   PubMed Web of Science ®Google Scholar
• McDermott Lisa M, Ebmeier Klaus P. A meta-analysis of depression severity and cognitive function. J Affect Disord. 2009;119(1–3):1–8. doi:10.1016/j.jad.2009.04.02219428120
   PubMed Web of Science ®Google Scholar
• Faust K, Nelson Brady D, Sarapas C, Pliskin Neil H. Depression and performance on the repeatable battery for the assessment of neuropsychological status. Appl Neuropsychol Adult. 2017;24(4):350–356. doi:10.1080/23279095.2016.118542627267513
   PubMed Web of Science ®Google Scholar
• Jaeger J, Berns S, Uzelac S, Davis-Conway S. Neurocognitive deficits and disability in major depressive disorder. Psychiatry Res. 2006;145(1):39–48. doi:10.1016/j.psychres.2005.11.01117045658
   PubMed Web of Science ®Google Scholar
• Hasselbalch Bo J, Ulla K, Vedel KL. Cognitive impairment in the remitted state of unipolar depressive disorder: a systematic review. J Affect Disord. 2011;134(1–3):20–31. doi:10.1016/j.jad.2010.11.01121163534
   PubMed Web of Science ®Google Scholar
• Schultz Susan K, Ellingrod Vicki L, Moser David J, et al. The influence of cognitive impairment and psychiatric symptoms on daily functioning in nursing facilities: a longitudinal study. Ann Clin Psychiatry. 2002;14(4):209–213. doi:10.3109/1040123020914745912630656
   PubMedGoogle Scholar
• Hinton LS, Farias T, Wegelin J. Neuropsychiatric symptoms are associated with disability in cognitively impaired Latino elderly with and without dementia: results from the sacramento area latino study on aging. Int J Geriatr Psychiatry. 2008;23(1):102–108. doi:10.1002/gps.195218058994
   PubMed Web of Science ®Google Scholar
• Lavretsky H, Zheng L, Weiner MW, Mungas D, Reed B, Kramer JH. Association of depressed mood and mortality in older adults with and without cognitive impairment in a prospective naturalistic study. Am J Psychiatry. 2010;167(5):589–597. doi:10.1176/appi.ajp.2009.0902028020160005
   PubMed Web of Science ®Google Scholar
• Okura T, Plassman Brenda L, Steffens David C, Llewellyn David J, Potter Guy G, Langa Kenneth M. Prevalence of neuropsychiatric symptoms and their association with functional limitations in older adults in the United States: the aging, demographics, and memory study. J Am Geriatr Soc. 2009;58(2):330–337. doi:10.1111/j.1532-5415.2009.02680.x
   Web of Science ®Google Scholar
• Guo J, Liu Z, Dai H, et al. Preliminary investigation of the influence of CREB1 gene polymorphisms on cognitive dysfunction in Chinese patients with major depression. Int J Neurosci. 2014;124(1):22–29. doi:10.3109/00207454.2013.81695623844928
   PubMed Web of Science ®Google Scholar
• Hui L, Han M, Du XD, et al. Serum ApoB levels in depressive patients: associated with cognitive deficits. Sci Rep. 2017;7(1):39992. doi:10.1038/srep3999228054633
   PubMed Web of Science ®Google Scholar
• Duric V, Banasr M, Stockmeier Craig A, et al. Altered expression of synapse and glutamate related genes in post-mortem hippocampus of depressed subjects. Int J Neuropsychopharmacol. 2013;16(1):69–82. doi:10.1017/S146114571200001622339950
   PubMed Web of Science ®Google Scholar
• Malki K, Pain O, Tosto MG, Du Rietz E, Carboni L, Schalkwyk LC. Identification of genes and gene pathways associated with major depressive disorder by integrative brain analysis of rat and human prefrontal cortex transcriptomes. Transl Psychiatry. 2015;5(3):e519. doi:10.1038/tp.2015.1525734512
   PubMed Web of Science ®Google Scholar
• Schratt Gerhard M, Tuebing F, Nigh Elizabeth A, et al. A brain-specific microRNA regulates dendritic spine development. Nature. 2006;439(7074):283–289. doi:10.1038/nature0436716421561
   PubMed Web of Science ®Google Scholar
• Nadim WD, Simion V, Benedetti H, Pichon C, Baril P, Morisset-Lopez S. MicroRNAs in neurocognitive dysfunctions: new molecular targets for pharmacological treatments? Curr Neuropharmacol. 2017;15(2):260–275. doi:10.2174/1570159X1466616070900144127396304
   PubMed Web of Science ®Google Scholar
• Baudry A, Mouillet-Richard S, Schneider B, Jean-Marie. L, Odile K. miR-16 targets the serotonin transporter: a new facet for adaptive responses to antidepressants. Science. 2010;329(5998):1537–1541. doi:10.1126/science.119369220847275
   PubMed Web of Science ®Google Scholar
• Hansen Katelin F, Karl O. MicroRNA as therapeutic targets for treatment of depression. Neuropsychiatr Dis Treat. 2013;9:1011–1021. doi:10.2147/NDT.S3481123935365
   PubMed Web of Science ®Google Scholar
• Lopez JP, Lim R, Cruceanu C, et al. miR-1202 is a primate-specific and brain-enriched microRNA involved in major depression and antidepressant treatment. Nat Med. 2014;20(7):764–768. doi:10.1038/nm.358224908571
   PubMed Web of Science ®Google Scholar
• Smalheiser Neil R, Lugli G, Rizavi HS, et al. MicroRNA expression is down-regulated and reorganized in prefrontal cortex of depressed suicide subjects. PLoS One. 2012;7(3):e33201. doi:10.1371/journal.pone.003320122427989
   PubMed Web of Science ®Google Scholar
• Smalheiser Neil R, Lugli G, Zhang H, et al. Expression of microRNAs and other small RNAs in prefrontal cortex in schizophrenia, bipolar disorder and depressed subjects. PLoS One. 2014;9(1):e86469. doi:10.1371/journal.pone.008646924475125
   PubMed Web of Science ®Google Scholar
• Belzeaux R, Bergon A, Jeanjean V, et al. Responder and nonresponder patients exhibit different peripheral transcriptional signatures during major depressive episode. Transl Psychiatry. 2012;2(11):e185. doi:10.1038/tp.2012.11223149449
   PubMed Web of Science ®Google Scholar
• Liu X, Zhang L, Cheng K, et al. Identification of suitable plasma-based reference genes for miRNAome analysis of major depressive disorder. J Affect Disord. 2014;163:133–139. doi:10.1016/j.jad.2013.12.03524479999
   PubMed Web of Science ®Google Scholar
• Oved K, Morag A, Pasmanik-Chor M, et al. Genome-wide miRNA expression profiling of human lymphoblastoid cell lines identifies tentative SSRI antidepressant response biomarkers. Pharmacogenomics. 2012;13(10):1129–1139. doi:10.2217/pgs.12.9322909203
   PubMed Web of Science ®Google Scholar
• Haramati S, Navon I, Issler O, et al. MicroRNA as repressors of stress-induced anxiety: the case of amygdalar miR-34. J Neurosci. 2011;31(40):14191–14203. doi:10.1523/JNEUROSCI.1673-11.201121976504
   PubMed Web of Science ®Google Scholar
• Bocchio-Chiavetto L, Maffioletti E, Bettinsoli P, et al. Blood microRNA changes in depressed patients during antidepressant treatment. Eur Neuropsychopharmacol. 2013;23(7):602–611. doi:10.1016/j.euroneuro.2012.06.01322925464
   PubMed Web of Science ®Google Scholar
• Zovoilis A, Agbemenyah HY, Agis-Balboa RC, et al. microRNA-34c is a novel target to treat dementias. EMBO J. 2011;30(20):4299–4308. doi:10.1038/emboj.2011.32721946562
   PubMed Web of Science ®Google Scholar
• Ning S, Lei L, Wang Y, et al. Preliminary comparison of plasma notch-associated microRNA-34b and −34c levels in drug naive, first episode depressed patients and healthy controls. J Affect Disord. 2016;194:109–114. doi:10.1016/j.jad.2016.01.01726807671
   PubMed Web of Science ®Google Scholar
• Xu C, Yang C, Zhang A, Xu Y, Li X, Liu Z. The interaction of mir-34b/c polymorphisms and negative life events increases susceptibility to major depressive disorder in han chinese population. Neurosci Lett. 2017;651:65–71. doi:10.1016/j.neulet.2017.04.06128461137
   PubMed Web of Science ®Google Scholar
• Yiqing H, Liu X, Liao Y, et al. Role of miR-34c in the cognitive function of epileptic rats induced by pentylenetetrazol. Mol Med Rep. 2018;17(3):4173–4180. doi:10.3892/mmr.2018.844129344671
   PubMed Web of Science ®Google Scholar
• Shu-e C, Tian J, Chen S, et al. Role of miR-34c in ketamine-induced neurotoxicity in neonatal mice hippocampus. Cell Biol Int. 2015;39(2):164–168. doi:10.1002/cbin.1034925052764
   PubMed Web of Science ®Google Scholar
• Li M, Lu S, Wang G, Feng L, Fu B, Zhong N. Emotion, working memory, and cognitive control in patients with first-onset and previously untreated minor depressive disorders. J Int Med Res. 2016;4(3):529–541. doi:10.1177/0300060516639169
   Web of Science ®Google Scholar
• Li M, Zhong N, Lu S, et al. Cognitive behavioral performance of untreated depressed patients with mild depressive symptoms. PLoS One. 2016;11(1):e0146356. doi:10.1371/journal.pone.014635626730597
   PubMed Web of Science ®Google Scholar
• Baune BT, Miller R, Mcafoose J, Johnson M, Quirk F, Mitchell D. The role of cognitive impairment in general functioning in major depression. Psychiatry Res. 2010;176(2–3):0–189. doi:10.1016/j.psychres.2008.12.001
   Web of Science ®Google Scholar
• Randolph C, Tierney MC, Mohr E, Chase TN. The repeatable battery for the assessment of neuropsychological status (RBANS): preliminary clinical validity. J Clin Exp Neuropsychol. 1998;20(3):310–319. doi:10.1076/jcen.20.3.310.8239845158
   PubMed Web of Science ®Google Scholar
• Sánchez-Cubillo I, Periáñez JA, Adrover-Roig D, et al. Construct validity of the trail making test: role of task-switching, working memory, inhibition/interference control, and visuomotor abilities. J Int Neuropsychol Soc. 2009;15(3):438–450. doi:10.1017/S135561770909062619402930
   PubMed Web of Science ®Google Scholar
• Gold JM, Queern C, Iannone VN, Buchanan RW. Repeatable battery for the assessment of neuropsychological status as a screening test in schizophrenia I: sensitivity, reliability, and validity. Am J Psychiatry. 1999;156(12):1944–1950. doi:10.1176/ajp.156.12.194410588409
   PubMed Web of Science ®Google Scholar
• Zhong N, Jiang H, Wu J, et al. Reliability and validity of the CogState battery Chinese language version in schizophrenia. PLoS One. 2013;8(9):e74258. doi:10.1371/journal.pone.007425824023931
   PubMed Web of Science ®Google Scholar
• Ning S, Xu Y, Wang Y, et al. The combined effect of norepinephrine transporter gene and negative life events in major depression of Chinese Han population. J Neural Transm. 2008;115(12):1681–1686. doi:10.1007/s00702-008-0109-518779921
   PubMed Web of Science ®Google Scholar
• Buetow KH, Edmonson M, MacDonald R, et al. High-throughput development and characterization of a genomewide collection of gene-based single nucleotide polymorphism markers by chip-based matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Proc Natl Acad Sci U S A. 2001;98(2):581–584. doi:10.1073/pnas.98.2.58111136232
   PubMed Web of Science ®Google Scholar
• Sun T, Gao Y, Tan W, et al. A six-nucleotide insertion-deletion polymorphism in the CASP8 promoter is associated with susceptibility to multiple cancers. Nat Genet. 2007;39(5):605–613. doi:10.1038/ng203017450141
   PubMed Web of Science ®Google Scholar
• Dupont WD, Plummer WD. Power and sample size calculations for studies involving linear regression. Control Clin Trials. 1998;19(6):589–601. doi:10.1016/S0197-2456(98)00037-39875838
   PubMedGoogle Scholar
• Ravnkilde B, Videbech P, Clemmensen K, Egander A, Rasmussen NA, Rosenberg R. Cognitive deficits in major depression. Scand J Psychol. 2002;43(3):239–251. doi:10.1111/1467-9450.0029212184479
   PubMed Web of Science ®Google Scholar
• Pakarinen M, Vanhanen S, Sinikallio S. Depressive burden is associated with a poorer surgical outcome among lumbar spinal stenosis patients: a 5-year follow-up study. Spine J. 2014;14(10):2392–2396. doi:10.1016/j.spinee.2014.01.04724486473
   PubMed Web of Science ®Google Scholar
• Williams RA, Hagerty BM, Cimprich B, Therrien B, Bay E, Oe H. Changes in directed attention and short-term memory in depression. J Psychiatr Res. 2000;34(3):227–238. doi:10.1016/S0022-3956(00)00012-110867118
   PubMed Web of Science ®Google Scholar
• Dwivedi Y. Evidence demonstrating role of microRNAs in the etiopathology of major depression. J Chem Neuroanat. 2011;42(2):142–156. doi:10.1016/j.jchemneu.2011.04.00221515361
   PubMed Web of Science ®Google Scholar
• Aschrafi A, Verheijen Jan M, Gordebeke Peter M, et al. MicroRNA-326 acts as a molecular switch in the regulation of midbrain urocortin 1 expression. J Psychiatry Neurosci. 2016;41(5):342–353. doi:10.1503/jpn.15015427045550
   PubMed Web of Science ®Google Scholar
• Rock PL, Roiser JP, Riedel WJ, Blackwell AD. Cognitive impairment in depression: a systematic review and meta-analysis. Psychol Med. 2014;44(10):2029–2040. doi:10.1017/S003329171300253524168753
   PubMed Web of Science ®Google Scholar
• Zaninotto L, Solmi M, Veronese N. A meta-analysis of cognitive performance in melancholic versus non-melancholic unipolar depression. J Affect Disord. 2016;201:15–24. doi:10.1016/j.jad.2016.04.03927156095
   PubMed Web of Science ®Google Scholar
• Neu P, Bajbouj M, Schilling A, Godemann F, Berman RM, Schlattmann P. Cognitive function over the treatment course of depression in middle-aged patients: correlation with brain MRI signal hyperintensities. J Psychiatr Res. 2005;39(2):129–135. doi:10.1016/j.jpsychires.2004.06.00415589560
   PubMed Web of Science ®Google Scholar
• O’Bryant SE, Hall JR, Cukrowicz KC, et al. The differential impact of depressive symptom clusters on cognition in a rural multi-ethnic cohort: a Project FRONTIER study. Int J Geriatr Psychiatry. 2011;26(2):199–205. doi:10.1002/gps.251420661882
   PubMed Web of Science ®Google Scholar
• Sexton CE, McDermott L, Kalu UG, et al. Exploring the pattern and neural correlates of neuropsychological impairment in late-life depression. Psychol Med. 2012;42(6):1195–1202. doi:10.1017/S003329171100235222030013
   PubMed Web of Science ®Google Scholar
• Andersson S, Hui L, Han M, Du XD. Neuropsychological function in unmedicated recurrent brief depression. J Affect Disord. 2010;125(1–3):155–164. doi:10.1016/j.jad.2009.12.02320085849
   PubMed Web of Science ®Google Scholar
• Nelson Brady D. Frontal brain asymmetry in depression with comorbid anxiety: a neuropsychological investigation. J Abnorm Psychol. 2012;121(3):579–591. doi:10.1037/a002758722428788
   PubMed Web of Science ®Google Scholar
• Meijsen JJ, Campbell A, Hayward C, Porteous DJ, Deary IJ, Marioni RE. Phenotypic and genetic analysis of cognitive performance in major depressive disorder in the generation scotland: scottish family health study. Transl Psychiatry. 2018;8(1):63. doi:10.1038/s41398-018-0111-029531327
   PubMed Web of Science ®Google Scholar
• Cullena B, Nichollb BI, Mackayc DF, Martina D, Smith DJ. Cognitive function and lifetime features of depression and bipolar disorder in a large population sample: cross-sectional study of 143,828 uk biobank participants. Eur Psychiatry. 2015;30(8):950–958. doi:10.1016/j.eurpsy.2015.08.00626647871
   PubMed Web of Science ®Google Scholar
• Baune Bernhard T, Oved K, Morag A, Pasmanik-Chor M. Impact of psychiatric and medical comorbidity on cognitive function in depression. Psychiatry Clin Neurosci. 2009;63(3):392–400. doi:10.1111/j.1440-1819.2009.01971.x19566772
   PubMed Web of Science ®Google Scholar
• Kao YC, Wang I, Tsai KJ. miRNA-34c overexpression causes dendritic loss and memory decline. Int J Mol Sci. 2018;19(8):2323. doi:10.3390/ijms19082323
   Web of Science ®Google Scholar
• Guo YJ, Zhang ZJ, Wang SH, et al. Notch1 signaling, hippocampal neurogenesis and behavioral responses to chronic unpredicted mild stress in adult ischemic rats. Prog Neuropsychopharmacol Biol Psychiatry. 2009;33(4):688–694. doi:10.1016/j.pnpbp.2009.03.02219336246
   PubMed Web of Science ®Google Scholar
• Wang S, Yuan Y, Xia W, et al. Neuronal apoptosis and synaptic density in the dentate gyrus of ischemic rats’ response to chronic mild stress and the effects of Notch signaling. PLoS One. 2012;7(8):e42828. doi:10.1371/journal.pone.004282822912748
   PubMed Web of Science ®Google Scholar